The ACTS program at the Hyundai Cancer Institute at CHOC receives recognition for their work to provide long-term care to cancer survivors.
CHOC earns national recognition for efforts to improve cardiac arrest survival
CHOC receives award for commitment to treating in-hospital cardiac arrests and helping to improve patient survival rates.
First batch of awardees announced for new Chief Scientific Officer small grant program
Research projects of the winners – 12 of 23 were awarded funding – range from virtual reality training to the use of AI to predict COVID-19.
New clinical evidence shifts approach to vesicoureteral reflux (VUR) care
The practice of treating vesicoureteral reflux (VUR) with follow-up tests is questioned by CHOC urologists because it’s often unnecessary.
Three-stage DBS results in better outcomes for secondary dystonia
A CHOC neuroscientist has developed a breakthrough method of DBS to treat secondary dystonia in pediatric patients.
Personalized medicine, surgical innovations advance pediatric brain tumor care
The Neuro-Oncology Treatment Program at CHOC is helping to shape the future of personalized medicine and surgical innovations.
